Satellos Bioscience Raises $57.2 Million Through Share and Pre-Funded Warrant Offering
I'm PortAI, I can summarize articles.
Satellos Bioscience Inc. has raised approximately $57.2 million through an underwritten public offering, issuing 5,168,019 common shares at $10.10 each and pre-funded warrants at $10.09999 each. The funds will primarily support ongoing research and development, including advancing SAT-3247 through clinical trials and other development programs.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments